PATIENTS AND METHODS : The IRENE ( Iressa RE-challenge in advanced , EGFR -mutated NSCLC patients who responded to an EGFR -TKI used as first-line or previous treatment ) ( Dutch association for pulmonologists [ NVALT ] -16 ) trial is a multicenter , open-label , single-arm , single-stage , phase II study to evaluate gefitinib rechallenge in EGFR -mutated NSCLC patients who were previously treated with a TKI followed by a subsequent line of treatment ( excluding EGFR -TKIs ) .